Preventing vincristine administration errors.
D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007262:Infusions, Intravenous; D007278:Injections, Spinal / Q000009:adverse effects; D007591:Joint Commission on Accreditation of Healthcare Organizations; D008508:Medication Errors / Q000009:adverse effects / Q000517:prevention & control*; D008510:Medication Systems, Hospital / Q000592:standards*; D018571:Sentinel Surveillance; D013346:Subarachnoid Space; D014481:United States; D014750:Vincristine / Q000008:administration & dosage* / Q000009:adverse effects
D000972:Antineoplastic Agents, Phytogenic; D014750:Vincristine